NKTR — Nektar Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapMomentum Trap

Annual balance sheet for Nektar Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	734	505	304	255	246
Net Total Accounts Receivable
Net Total Receivables	22.5	5.98	1.21	0	1.78
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	796	546	331	261	266
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	178	85.9	36.9	11.8	5
Net Goodwill
Long Term Investments
Other Long Term Assets
Total Assets	1,117	711	398	304	280
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	85.2	68.2	51.3	61.4	53.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	438	344	267	243	191
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	680	367	131	60.7	89.8
Total Liabilities & Shareholders' Equity	1,117	711	398	304	280
Total Common Shares Outstanding